StockMarketWire.com - Imperial Innovations Group has led a $28m funding round for Oxford Immunotec, alongside Invesco Perpetual and existing investors.

Oxford Immunotec is a medical diagnostics company developing novel diagnostic tests in the field of immunological disease.

Spun-out from the University of Oxford in 2002, Oxford Immunotec is a well-established, international business, with rapid revenue growth.

Oxford Immunotec will use the funds raised to develop further its logistics, sales and delivery infrastructure in the US.

In 2011 it increased its lab testing capacity by building a new CLIA lab facility in Memphis, through which it can achieve unparalleled US national coverage and turnaround time.

At 8:03am: [LON:IVO] Ivory & Sime Optimum share price was -9p at 287.5p


Story provided by StockMarketWire.com